Literature DB >> 34285191

Defining relative mutational difficulty to understand cancer formation.

Lin Shan1,2, Jiao Yu1,2, Zhengjin He1,2, Shishuang Chen1,2, Mingxian Liu1,2, Hongyu Ding1,2, Liang Xu1,2, Jie Zhao1,2, Ailing Yang1,2, Hai Jiang3,4.   

Abstract

Most mutations in human cancer are low-frequency missense mutations, whose functional status remains hard to predict. Here, we show that depending on the type of nucleotide change and the surrounding sequences, the tendency to generate each type of nucleotide mutations varies greatly, even by several hundred folds. Therefore, a cancer-promoting mutation may appear only in a small number of cancer cases, if the underlying nucleotide change is too difficult to generate. We propose a method that integrates both the original mutation counts and their relative mutational difficulty. Using this method, we can accurately predict the functionality of hundreds of low-frequency missense mutations in p53, PTEN, and INK4A. Many loss-of-function p53 mutations with dominant negative effects were identified, and the functional importance of several regions in p53 structure were highlighted by this analysis. Our study not only established relative mutational difficulties for different types of mutations in human cancer, but also showed that by incorporating such a parameter, we can bring new angles to understanding cancer formation.
© 2020. The Author(s).

Entities:  

Year:  2020        PMID: 34285191     DOI: 10.1038/s41421-020-0177-8

Source DB:  PubMed          Journal:  Cell Discov        ISSN: 2056-5968            Impact factor:   10.849


  42 in total

Review 1.  Hepatocellular carcinoma pathogenesis: from genes to environment.

Authors:  Paraskevi A Farazi; Ronald A DePinho
Journal:  Nat Rev Cancer       Date:  2006-09       Impact factor: 60.716

Review 2.  Translating p53 into the clinic.

Authors:  Chit Fang Cheok; Chandra S Verma; José Baselga; David P Lane
Journal:  Nat Rev Clin Oncol       Date:  2010-10-26       Impact factor: 66.675

Review 3.  Mechanisms underlying mutational signatures in human cancers.

Authors:  Thomas Helleday; Saeed Eshtad; Serena Nik-Zainal
Journal:  Nat Rev Genet       Date:  2014-07-01       Impact factor: 53.242

Review 4.  Why are there hotspot mutations in the TP53 gene in human cancers?

Authors:  Evan H Baugh; Hua Ke; Arnold J Levine; Richard A Bonneau; Chang S Chan
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

Review 5.  When mutants gain new powers: news from the mutant p53 field.

Authors:  Ran Brosh; Varda Rotter
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

6.  Mutational signatures associated with tobacco smoking in human cancer.

Authors:  Ludmil B Alexandrov; Young Seok Ju; Kerstin Haase; Peter Van Loo; Iñigo Martincorena; Serena Nik-Zainal; Yasushi Totoki; Akihiro Fujimoto; Hidewaki Nakagawa; Tatsuhiro Shibata; Peter J Campbell; Paolo Vineis; David H Phillips; Michael R Stratton
Journal:  Science       Date:  2016-11-04       Impact factor: 47.728

7.  A Compendium of Mutational Signatures of Environmental Agents.

Authors:  Jill E Kucab; Xueqing Zou; Sandro Morganella; Madeleine Joel; A Scott Nanda; Eszter Nagy; Celine Gomez; Andrea Degasperi; Rebecca Harris; Stephen P Jackson; Volker M Arlt; David H Phillips; Serena Nik-Zainal
Journal:  Cell       Date:  2019-04-11       Impact factor: 41.582

Review 8.  Putting p53 in Context.

Authors:  Edward R Kastenhuber; Scott W Lowe
Journal:  Cell       Date:  2017-09-07       Impact factor: 41.582

9.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

10.  Reduced mutation rate in exons due to differential mismatch repair.

Authors:  Joan Frigola; Radhakrishnan Sabarinathan; Loris Mularoni; Ferran Muiños; Abel Gonzalez-Perez; Núria López-Bigas
Journal:  Nat Genet       Date:  2017-11-06       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.